Pidotimod
CAS No. 121808-62-6
Pidotimod ( PGT/1A )
产品货号. M10818 CAS No. 121808-62-6
Pidotimod 是一种口服活性二肽免疫刺激剂 (immunostimulant),具有适应性和先天免疫应答的免疫调节特性。Pidotimod 增加巨噬细胞活性和体液免疫功能。Pidotimod 可用于慢性支气管炎、慢性阻塞性肺疾病 (COPD)、支气管扩张、慢性特发性荨麻疹等的研究。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 50MG | ¥152 | 有现货 |
|
| 100MG | ¥191 | 有现货 |
|
| 500MG | ¥438 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥226 | 有现货 |
|
生物学信息
-
产品名称Pidotimod
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Pidotimod 是一种口服活性二肽免疫刺激剂 (immunostimulant),具有适应性和先天免疫应答的免疫调节特性。Pidotimod 增加巨噬细胞活性和体液免疫功能。Pidotimod 可用于慢性支气管炎、慢性阻塞性肺疾病 (COPD)、支气管扩张、慢性特发性荨麻疹等的研究。
-
产品描述Pidotimod is an immunostimulant.(In Vivo):In toxicology study in animals, Pidotimod (oral gavage; 800 mg/kg;12 months) is non-toxic in rats and is non-toxic dogs at 600 mg/kg. Pidotimod is non-teratogenic in rats (600 mg/kg orally or 1000 mg/kg IV) and has no effects on subsequent embryofoetal development in rats (up to 1000 mg/kg/day),it has no perinatal or postnatal toxic effects in rats (600 mg/kg orally).In ex vivo experiments in mice, Pidotimod (intraperitoneal administration; 200 mg/kg; 5 days) potentiats natural killer (NK) cell activity and produces an increase in the proliferative response to mitogens such as concanavalin A (ConA) and interleukin-2 (IL-2).Pidotimod (intraperitoneal administration; 10-100 mg/kg) normalizes depletion of peritoneal macrophage numbers, and significantly increases macrophage superoxide anion (O2–) production in methylprednisolone-induced immunosuppressed mice.
-
体外实验——
-
体内实验In toxicology study in animals, Pidotimod (oral gavage; 800 mg/kg;12 months) is non-toxic in rats and is non-toxic dogs at 600 mg/kg. Pidotimod is non-teratogenic in rats (600 mg/kg orally or 1000 mg/kg IV) and has no effects on subsequent embryofoetal development in rats (up to 1000 mg/kg/day),it has no perinatal or postnatal toxic effects in rats (600 mg/kg orally).In ex vivo experiments in mice, Pidotimod (intraperitoneal administration; 200 mg/kg; 5 days) potentiats natural killer (NK) cell activity and produces an increase in the proliferative response to mitogens such as concanavalin A (ConA) and interleukin-2 (IL-2). Pidotimod (intraperitoneal administration; 10-100 mg/kg) normalizes depletion of peritoneal macrophage numbers, and significantly increases macrophage superoxide anion (O2–) production in methylprednisolone-induced immunosuppressed mice.
-
同义词PGT/1A
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域Inflammation/Immunology
-
适应症——
化学信息
-
CAS Number121808-62-6
-
分子量244.27
-
分子式C9H12N2O4S
-
纯度>98% (HPLC)
-
溶解度Water: 10 mg/mL (40.93 mM); DMSO: 49 mg/mL (200.59 mM)
-
SMILESO=C([C@H]1N(C([C@H](CC2)NC2=O)=O)CSC1)O
-
化学全称(R)-3-((S)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Clemente E, et al. Arzneimittelforschung, 1994, 44(12A), 1490-1494.
产品手册
关联产品
-
Pam3CSK4 TFA
一种 Toll 样受体 1/2 (TLR1/2) 激动剂,对人 TLR1/2 的 EC50 为 0.47 ng/mL。
-
INCB3619
INCB3619 是一种选择性的,具有口服活性的 ADAM 抑制剂,作用于 ADAM10 和 ADAM17 的 IC50 值分别是 22 nM和 14 nM。INCB3619 具有抗肿瘤活性。
-
LP-922761
LP-922761 是一种有效的,选择性的,具有口服活性的 AAK1 抑制剂,在酶和细胞分析中 IC50 分别为 4.8 nM 和 7.6 nM。LP-922761 还抑制 BMP-2 诱导蛋白激酶 (BIKE),IC50 为 24 nM。LP-922761 对细胞 GAK,阿片类活性分子,肾上腺素 α2 或 GABAa 受体无明显活性。
021-51111890
购物车()
sales@molnova.cn

